Chemotherapy (CT) reduced the populations of CTCs with the phenotype ALDH+, CD87+, CD87+CD117+, EGF+Axl+, and CD276+CD117+ in the blood of patients with SCLC in compared to patients before the treatment (Figure 7). The gene discussed is AXL; the disease is small cell lung carcinoma.